Skip to main content
. 2023 Feb 17;15(4):1010. doi: 10.3390/nu15041010

Figure 1.

Figure 1

Study flowchart. Randomization, allocation and follow-up in intention-to-treat and per protocol (PP) populations. SF, standard formula; α-lac-EW, experimental formula with α-lactalbumin-enriched whey; CGMP-RW, experimental formula with reduced CGMP whey; BF, breast-fed. Reasons for lost to follow-up: * Gastrointestinal adverse events, such as vomiting, stomach ache, flatulence or constipation. ** Congenital genetic disease affecting growth.